Severe chronic plaque psoriasis paediatric - adalimumab or ustekinumab - initial, change or recommencement authority application form (PB320)

Use this form to apply for initial, change or recommencing PBS-subsidised treatment with adalimumab or ustekinumab for patients under 18 years with severe chronic plaque psoriasis.

Page last updated: 1 September 2025.
QC 55530